ATC code M
Source: Wikipedia, the free encyclopedia.
Pharmaceutical drug classification
ATC code M: Musculo-skeletal system |
---|
|
Other ATC codes |
ATC code M Musculo-skeletal system is a section of the
Codes for
ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code M". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QM". WHO Collaborating Centre for Drug Statistics Methodology.
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
profens ) |
|
n-arylanthranilic acids ( fenamates ) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
Specific antirheumatic products / DMARDs (M01C) | |
---|---|
Quinolines | |
Gold preparations | |
Other | |
|
|
| |||||||
---|---|---|---|---|---|---|---|---|
Capsaicin derivatives | ||||||||
Other |
|
| |||||
---|---|---|---|---|---|---|
Depolarizing |
| |||||
ACh release inhibitors |
Uricosurics |
| ||||
---|---|---|---|---|---|
Xanthine oxidase inhibitors |
| ||||
Mitotic inhibitors | |||||
Other | |||||
|
Drugs for treatment of bone diseases (M05) | |
---|---|
Bisphosphonates | |
Bone morphogenetic proteins |
|
Other |
|
| |
---|---|
Quinine and derivatives | |
Enzymes | |
Gene therapies | |
Antisense oligonucleotides | |
Glucocorticoids | |
Histone deacetylase inhibitors | |
Other | |
|